ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+7.09%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$354M
AUM Growth
+$354M
(+14%)
Cap. Flow
+$25.3M
Cap. Flow
% of AUM
7.15%
Top 10 Holdings %
Top 10 Hldgs %
34.16%
Holding
110
New
22
Increased
38
Reduced
31
Closed
18
Top Buys
| 1 |
McKesson
MCK
|
$10M |
| 2 |
Thermo Fisher Scientific
TMO
|
$9.41M |
| 3 |
iRhythm Technologies
IRTC
|
$7.03M |
| 4 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$6.97M |
| 5 |
Dentsply Sirona
XRAY
|
$6.32M |
Top Sells
| 1 |
CTLT
CATALENT, INC.
CTLT
|
$8.25M |
| 2 |
VWR
VWR Corporation
VWR
|
$7.23M |
| 3 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$5.2M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
$4.63M |
| 5 |
Hologic
HOLX
|
$4.59M |
Sector Composition
| 1 | Healthcare | 88.14% |
| 2 | Financials | 2.42% |
| 3 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KITE
51
DELISTED
Kite Pharma, Inc.
KITE
| $1.7M | 0.48% | +16,400 | New | +$1.7M |
|
52
Puma Biotechnology
PBYI
$254M
| $1.69M | 0.48% | 19,300 -10,300 | -35% | -$900K |
|
53
Revvity
RVTY
$10.5B
| $1.66M | 0.47% | 24,400 +12,807 | +110% | +$873K |
|
54
Encompass Health
EHC
$12.3B
| $1.53M | 0.43% | 31,604 -78,400 | -71% | -$3.8M |
|
55
Illumina
ILMN
$15.8B
| $1.53M | 0.43% | 8,800 -1,900 | -18% | -$330K |
|
56
Orthofix Medical
OFIX
$592M
| $1.41M | 0.4% | +30,400 | New | +$1.41M |
|
|
RXDX
57
DELISTED
Ignyta, Inc.
RXDX
| $1.37M | 0.39% | +132,400 | New | +$1.37M |
|
|
ENTL
58
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $1.3M | 0.37% | +78,600 | New | +$1.3M |
|
59
Cigna
CI
$80.3B
| $1.24M | 0.35% | 7,400 +4,400 | +147% | +$737K |
|
60
Amicus Therapeutics
FOLD
$2.34B
| $1.2M | 0.34% | 118,800 -104,500 | -47% | -$1.05M |
|
61
Labcorp
LH
$23.1B
| $1.11M | 0.31% | 7,212 -13,100 | -64% | -$2.02M |
|
|
PTLA
62
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.08M | 0.3% | +19,200 | New | +$1.08M |
|
|
ZSAN
63
DELISTED
Zosano Pharma Corporation
ZSAN
| $1.06M | 0.3% | 751,380 +154,200 | +26% | +$217K |
|
|
RDUS
64
DELISTED
Radius Health, Inc.
RDUS
| $1.06M | 0.3% | +23,400 | New | +$1.06M |
|
|
RNTX
65
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $993K | 0.28% | +89,100 | New | +$993K |
|
66
Zoetis
ZTS
$69.3B
| $967K | 0.27% | 15,500 -60,200 | -80% | -$3.76M |
|
67
Humana
HUM
$36.5B
| $962K | 0.27% | 4,000 +400 | +11% | +$96.2K |
|
68
CONMED
CNMD
$1.68B
| $953K | 0.27% | 18,700 -8,400 | -31% | -$428K |
|
69
BioMarin Pharmaceuticals
BMRN
$11.2B
| $845K | 0.24% | 9,300 +4,200 | +82% | +$382K |
|
70
Nektar Therapeutics
NKTR
$568M
| $837K | 0.24% | +42,800 | New | +$837K |
|
|
71
Hologic
HOLX
$14.9B
| $836K | 0.24% | 18,429 -101,129 | -85% | -$4.59M |
|
72
Eli Lilly
LLY
$657B
| $790K | 0.22% | 9,600 -8,100 | -46% | -$667K |
|
|
AKRX
73
DELISTED
Akorn, Inc.
AKRX
| $751K | 0.21% | 22,400 -135,800 | -86% | -$4.55M |
|
|
IMGN
74
DELISTED
Immunogen Inc
IMGN
| $743K | 0.21% | +104,500 | New | +$743K |
|
75
ANI Pharmaceuticals
ANIP
$2.03B
| $730K | 0.21% | +15,600 | New | +$730K |
|